In this study, we explored the concurrence of monoallelic and biallelic del(11q)/ATM and TP53 lesions by generating isogenic CRISPR/Cas9 in vitro models mimicking the genetic heterogeneity we observed in a high‐risk cohort of del(11q) CLL patients. The gene discussed is ATM; the disease is B-cell chronic lymphocytic leukemia.